Kakil Ibrahim Rasul

738 total citations
48 papers, 495 citations indexed

About

Kakil Ibrahim Rasul is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Kakil Ibrahim Rasul has authored 48 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Kakil Ibrahim Rasul's work include Lung Cancer Treatments and Mutations (10 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastric Cancer Management and Outcomes (6 papers). Kakil Ibrahim Rasul is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastric Cancer Management and Outcomes (6 papers). Kakil Ibrahim Rasul collaborates with scholars based in Qatar, Saudi Arabia and United Arab Emirates. Kakil Ibrahim Rasul's co-authors include Shahab Uddin, Syed Shadab Raza, Mamoun Elawad, Soldano Ferrone, Cristina Maccalli, Abdalla Awidi, Rachel Kerr, Abdul Rahman Jazieh, Hartmut Goldschmidt and Ayman El‐Menyar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Kakil Ibrahim Rasul

39 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kakil Ibrahim Rasul Qatar 9 192 183 122 116 63 48 495
Ioannis D. Kostakis Greece 10 197 1.0× 239 1.3× 79 0.6× 107 0.9× 95 1.5× 14 530
Ertao Zhai China 14 195 1.0× 350 1.9× 139 1.1× 147 1.3× 95 1.5× 30 605
Hyeon Jeong Oh South Korea 14 243 1.3× 215 1.2× 87 0.7× 92 0.8× 94 1.5× 37 508
Ahmad Najem Belgium 15 264 1.4× 405 2.2× 113 0.9× 83 0.7× 48 0.8× 30 669
Zhijun Xu China 11 126 0.7× 317 1.7× 146 1.2× 117 1.0× 46 0.7× 28 558
Abdurahman Alloghbi United States 7 183 1.0× 317 1.7× 91 0.7× 128 1.1× 33 0.5× 19 589
Quanli Han China 13 175 0.9× 192 1.0× 130 1.1× 90 0.8× 47 0.7× 33 411
Williams Fajardo Peru 6 129 0.7× 178 1.0× 108 0.9× 105 0.9× 63 1.0× 9 394

Countries citing papers authored by Kakil Ibrahim Rasul

Since Specialization
Citations

This map shows the geographic impact of Kakil Ibrahim Rasul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kakil Ibrahim Rasul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kakil Ibrahim Rasul more than expected).

Fields of papers citing papers by Kakil Ibrahim Rasul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kakil Ibrahim Rasul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kakil Ibrahim Rasul. The network helps show where Kakil Ibrahim Rasul may publish in the future.

Co-authorship network of co-authors of Kakil Ibrahim Rasul

This figure shows the co-authorship network connecting the top 25 collaborators of Kakil Ibrahim Rasul. A scholar is included among the top collaborators of Kakil Ibrahim Rasul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kakil Ibrahim Rasul. Kakil Ibrahim Rasul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamad, Abdullah, et al.. (2024). EE360 Economic Impact of Adopting Lanreotide for Patients With Acromegaly and GEP-NET in Qatar. Value in Health. 27(12). S125–S125.
4.
Waked, Imam, Kakil Ibrahim Rasul, Wael Abdel‐Razek, et al.. (2023). Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region. Liver International. 43(10). 2062–2077. 5 indexed citations
5.
Kourié, Hampig Raphaël, et al.. (2023). The first Middle East and North Africa expert consensus recommendations for management of advanced gastric cancer. Future Oncology. 19(21). 1451–1459. 2 indexed citations
6.
Daugherty, Emily, et al.. (2022). Mammary analogue secretory carcinoma presenting with cervical lymphadenopathy. International Journal of Surgery Case Reports. 95(C). 107132–107132. 3 indexed citations
7.
Farhat, Fadi, Bassim Al Bahrani, Eman Sbaity, et al.. (2020). Comprehensive review into the challenges of gastrointestinal tumors in the Gulf and Levant countries. World Journal of Clinical Cases. 8(3). 487–503. 5 indexed citations
8.
Rasul, Kakil Ibrahim, et al.. (2019). <p>Pancytopenia And Limbic Encephalopathy Complicating Immunotherapy For Clear Cell Endometrial Cancer With Microsatellite Instability-High (MSI-H)</p>. OncoTargets and Therapy. Volume 12. 9965–9973. 5 indexed citations
9.
Jazieh, Abdul Rahman, et al.. (2019). The Study of Druggable Targets in Nonsquamous Non-Small-Cell Lung Cancer in the Middle East and North Africa. SHILAP Revista de lepidopterología. 2(1). 4–7. 8 indexed citations
10.
Rasul, Kakil Ibrahim, et al.. (2018). Epidemiology and tumor characteristics of gastrointestinal stromal tumors in KRG territories. SHILAP Revista de lepidopterología. 4(2).
11.
Rasul, Kakil Ibrahim, et al.. (2018). The Epidemiology of Colorectal Cancer in Erbil. 1(2). 1–6. 2 indexed citations
12.
Maccalli, Cristina, Kakil Ibrahim Rasul, Mamoun Elawad, & Soldano Ferrone. (2018). The role of cancer stem cells in the modulation of anti-tumor immune responses. Seminars in Cancer Biology. 53. 189–200. 80 indexed citations
13.
Rasul, Kakil Ibrahim, et al.. (2015). Can we use Sorafenib for advanced Hepatocellular Carcinoma (HCC) Child Pugh B?. PubMed. 1(17). 82–4. 2 indexed citations
14.
Zaidan, Manal, et al.. (2015). Assessing prescribing patterns for the prevention of chemotherapy-induced nausea and vomiting in the national center for cancer care and research. Saudi Pharmaceutical Journal. 23(4). 381–387. 4 indexed citations
15.
Al‐Thani, Hassan, et al.. (2014). Clinical presentation, management and outcomes of gastrointestinal stromal tumors. International Journal of Surgery. 12(10). 1127–1133. 23 indexed citations
16.
Jazieh, Abdul Rahman, Kakil Ibrahim Rasul, Jamal Zekri, et al.. (2013). Epidermal growth factor receptor mutation (EGFRMUT) in non-small cell lung cancer (NSCLC) in the Middle East.. Journal of Clinical Oncology. 31(15_suppl). e19035–e19035. 3 indexed citations
17.
Rasul, Kakil Ibrahim, et al.. (2009). Ruptured spleen in factor XIII deficiency. 1(1). 8–11. 2 indexed citations
18.
Rasul, Kakil Ibrahim & Rachel Kerr. (2009). Cetuximab plus chemotherapy in patients with advanced NSCLC. Nature Reviews Clinical Oncology. 6(9). 499–500. 5 indexed citations
19.
Heß, Thomas, Gerlinde Egerer, Bernd Kasper, et al.. (2006). Atypical manifestations of multiple myeloma: Radiological appearance. European Journal of Radiology. 58(2). 280–285. 17 indexed citations
20.
Rasul, Kakil Ibrahim, et al.. (2003). Study of HER2/neu status in Qatari women with breast carcinoma.. PubMed. 24(8). 832–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026